Detalhe da pesquisa
1.
Blocking soluble TNFα sensitizes HER2-positive breast cancer to trastuzumab through MUC4 downregulation and subverts immunosuppression.
J Immunother Cancer
; 11(3)2023 03.
Artigo
em Inglês
| MEDLINE | ID: mdl-36889811
2.
Halting ErbB-2 isoforms retrograde transport to the nucleus as a new theragnostic approach for triple-negative breast cancer.
Cell Death Dis
; 13(5): 447, 2022 05 09.
Artigo
em Inglês
| MEDLINE | ID: mdl-35534460
3.
Canonical ErbB-2 isoform and ErbB-2 variant c located in the nucleus drive triple negative breast cancer growth.
Oncogene
; 39(39): 6245-6262, 2020 09.
Artigo
em Inglês
| MEDLINE | ID: mdl-32843720
4.
Nuclear PDCD4 Expression Defines a Subset of Luminal B-Like Breast Cancers with Good Prognosis.
Horm Cancer
; 11(5-6): 218-239, 2020 10.
Artigo
em Inglês
| MEDLINE | ID: mdl-32632815
5.
Correction: Halting ErbB-2 isoforms retrograde transport to the nucleus as a new theragnostic approach for triple-negative breast cancer.
Cell Death Dis
; 14(12): 833, 2023 Dec 15.
Artigo
em Inglês
| MEDLINE | ID: mdl-38102106
6.
Tumores hipofisarios, casuística de Anatomía Patológica / Pituitary tumors: anatomopathological reports
Prensa méd. argent
; 104(6): 288-294, Ago2018. fig, graf, tab
Artigo
em Espanhol
| LILACS, BINACIS | ID: biblio-1051238